Validation of a point of care troponin assay in real life emergency department conditions

EMA - Emergency Medicine Australasia

Volumn 21, Issue 4, 2009, Pages 286-292

  Loten, Conrad ^a   Attia, John ^a,b   Hullick, Carolyn ^a   Marley, John ^c   McElduff, Patrick ^d  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Emergency medicine; Point of care system; Troponin

Indexed keywords

TROPONIN I;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EMERGENCY WARD; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; POINT OF CARE TESTING; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 68749098597     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2009.01198.x     Document Type: Article

References (11)

1. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarctione. J. Am. Coll. Cardiol. 2007 50 : e1 157.
2. Apple FS, Murakami M, Christenson R et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin. Chim. Acta. 2004 345 : 123 7.
3. Apple FS, Ler R, Chung A, Berger MJ, Murakami MM. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin. Chem. 2006 52 : 322 5.
4. Bock JL, Singer AJ, Thode HC. Comparison of emergency department patient classification by point of care and central laboratory methods for cardiac troponin. Am. J. Clin. Pathol. 2008 130 : 132 5.
5. Apple FS, Wu AH, Jaffe AS et al. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 2002 144 : 981 6.
6. International Federation of Clinical Chemistry. Standardisation of Markers of Cardiac Damage (CHSMCD). [Cited 9 June 2009.] Available from URL: http://www.ifcc.org/PDF/IFCC-Troponin-Web-Page-Table-of-Assays-Oct-2008.pdf
7. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischemic heart disease. Heart 2008 94 : 1335 41.
8. Panteghini M, Pagani F, Yeo KTJ et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin. Chem. 2004 50 : 327 32.
9. Henrikson CA, Howell EE, Bush DE et al. Prognostic usefulness of marginal troponin T elevation. Am. J. Cardiol. 2004 93 : 275 9.
10. deFilippi CR, Tocchi M, Parmar RJ et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes angiographic correlates and long-term clinical outcomes. J. Am. Coll. Cardiol. 2000 35 : 1827 34.
11. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin. Chem. 2006 52 : 832 7.